Gavend M M, Serre-Debeauvais F, Gavend M R, Pastrello D, Caron F, Baragatti G
Laboratoire de Pharmacologie, Faculté de Médecine de Grenoble, La Tronche, France.
Biomed Pharmacother. 1987;41(7):400-6.
The effects of ethylketocyclazocine (EKC) and ketocyclazocine (KC), benzomorphan derivatives proposed as kappa opioid receptor agonists, were studied by measuring changes in the levels of dopamine (DA), noradrenaline (NA), 5-hydroxytryptamine (5-HT), and their major metabolites, DOPAC, HVA, MHPG-SO4, 5-HIAA, in different regions of rat brain. Doses ranging from 1 to 10 mg/kg were tested. EKC decreased the levels of DOPAC and HVA in striatum, and increased DA concentrations, EKC markedly increased the levels of MHPG-SO4 in hypothalamus, but not in cortex, midbrain and pons-medulla. There was a non-significant decrease in NA concentrations. EKC increased the levels of 5-HIAA in hypothalamus and also in cortex, midbrain and pons-medulla, while the levels of 5-HT were increased. On the whole, similar neurochemical effects were observed after KC administration. These data were discussed in relation to the behavioral actions caused in rats by EKC and KC, including the increase in food intake, and they raise the possibility that the hypothalamic noradrenergic system participate in feeding behavior of these drugs.
通过测量大鼠脑不同区域中多巴胺(DA)、去甲肾上腺素(NA)、5-羟色胺(5-HT)及其主要代谢产物3,4-二羟基苯乙酸(DOPAC)、高香草酸(HVA)、3-甲氧基-4-羟基苯乙二醇硫酸酯(MHPG-SO4)、5-羟吲哚乙酸(5-HIAA)水平的变化,研究了乙基酮环唑新(EKC)和酮环唑新(KC)这两种被认为是κ阿片受体激动剂的苯并吗啡烷衍生物的作用。测试剂量范围为1至10毫克/千克。EKC降低了纹状体中DOPAC和HVA的水平,并增加了DA浓度,EKC显著增加了下丘脑而非皮质、中脑和脑桥-延髓中MHPG-SO4的水平。NA浓度有不显著的降低。EKC增加了下丘脑以及皮质、中脑和脑桥-延髓中5-HIAA的水平,同时5-HT水平也增加。总体而言,给予KC后观察到了类似的神经化学作用。结合EKC和KC对大鼠产生的行为作用,包括食物摄入量增加,对这些数据进行了讨论,这些数据增加了下丘脑去甲肾上腺素能系统参与这些药物摄食行为的可能性。